Yüklüyor......
Infectious complications of rituximab therapy in renal disease
Rituximab, an anti-CD20 monoclonal antibody, was originally used to treat B-cell malignancies. Its use has significantly increased in recent years, as it is now also used to treat a variety of autoimmune diseases including rheumatoid arthritis and ANCA-associated vasculitis (AAV). Initial studies su...
Kaydedildi:
| Yayımlandı: | Clin Kidney J |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Oxford University Press
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5570071/ https://ncbi.nlm.nih.gov/pubmed/28852481 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfx038 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|